FDA Approves First-Ever Gene Therapy to Restore Hearing

Wall Street Journal Wall Street Journal

Regeneron’s drug restored hearing in 11 of 12 children in a rare, inherited condition that causes deafness.

Read full article at Wall Street Journal →